Intuitively, R&D, accounting for about 20% of drug revenue, would be reduced as profit declines. The Congressional Budget Office (CBO) estimated that:
me-too drugs
In Forbes, Dr. Josh Bloom, American Council on Science and Health Director of Chemical and Pharmaceutical Sciences, and Dr. Henry I.
Before we start, congratulations are in order.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
